Tamuli B, Biswas S
Methods Mol Biol. 2025; 2909:245-256.
PMID: 40029526
DOI: 10.1007/978-1-0716-4442-3_16.
Ende Z, Mishina M, Kauffman R, Kumar A, Kumari R, Knight P
J Immunol Methods. 2024; 534:113768.
PMID: 39447635
PMC: 11585411.
DOI: 10.1016/j.jim.2024.113768.
Rollenske T, Murugan R, Wardemann H, Busse C
Methods Mol Biol. 2024; 2865:103-124.
PMID: 39424722
DOI: 10.1007/978-1-0716-4188-0_5.
Schlotheuber L, Luchtefeld I, Eyer K
Lab Chip. 2024; 24(5):1207-1225.
PMID: 38165819
PMC: 10898418.
DOI: 10.1039/d3lc00887h.
Xu H, Xiang X, Ding W, Dong W, Hu Y
Microorganisms. 2023; 11(12).
PMID: 38138080
PMC: 10746006.
DOI: 10.3390/microorganisms11122936.
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections.
Ormundo L, Barreto C, Tsuruta L
Viruses. 2023; 15(11).
PMID: 38005854
PMC: 10675117.
DOI: 10.3390/v15112177.
A Customizable Suite of Methods to Sequence and Annotate Cattle Antibodies.
Ramirez Valdez K, Nzau B, Dorey-Robinson D, Jarman M, Nyagwange J, Schwartz J
Vaccines (Basel). 2023; 11(6).
PMID: 37376488
PMC: 10302312.
DOI: 10.3390/vaccines11061099.
Construction of a Hantaan Virus Phage Antibody Library and Screening for Potential Neutralizing Activity.
Li Z, Zhang H, Yu X, Zhang Y, Chen L
Viruses. 2023; 15(5).
PMID: 37243121
PMC: 10221454.
DOI: 10.3390/v15051034.
Bioengineering of Antibody Fragments: Challenges and Opportunities.
Pirkalkhoran S, Grabowska W, Kashkoli H, Mirhassani R, Guiliano D, Dolphin C
Bioengineering (Basel). 2023; 10(2).
PMID: 36829616
PMC: 9952581.
DOI: 10.3390/bioengineering10020122.
A new dawn for monoclonal antibodies against antimicrobial resistant bacteria.
Troisi M, Marini E, Abbiento V, Stazzoni S, Andreano E, Rappuoli R
Front Microbiol. 2023; 13:1080059.
PMID: 36590399
PMC: 9795047.
DOI: 10.3389/fmicb.2022.1080059.
Development of therapeutic antibodies for the treatment of diseases.
Wang Z, Wang G, Lu H, Li H, Tang M, Tong A
Mol Biomed. 2022; 3(1):35.
PMID: 36418786
PMC: 9684400.
DOI: 10.1186/s43556-022-00100-4.
Recent Progress in the Discovery and Development of Monoclonal Antibodies against Viral Infections.
Mokhtary P, Pourhashem Z, Mehrizi A, Sala C, Rappuoli R
Biomedicines. 2022; 10(8).
PMID: 36009408
PMC: 9405509.
DOI: 10.3390/biomedicines10081861.
Production of PfEMP1-Specific Human Monoclonal Antibodies from Naturally Immune Individuals.
Walker M, Barfod L
Methods Mol Biol. 2022; 2470:407-421.
PMID: 35881362
DOI: 10.1007/978-1-0716-2189-9_30.
Antibodies to combat viral infections: development strategies and progress.
Pantaleo G, Correia B, Fenwick C, Joo V, Perez L
Nat Rev Drug Discov. 2022; 21(9):676-696.
PMID: 35725925
PMC: 9207876.
DOI: 10.1038/s41573-022-00495-3.
Review: The Nose as a Route for Therapy. Part 2 Immunotherapy.
Padayachee Y, Flicker S, Linton S, Cafferkey J, Kon O, Johnston S
Front Allergy. 2022; 2:668781.
PMID: 35387044
PMC: 8974912.
DOI: 10.3389/falgy.2021.668781.
Generation of a cost-effective cell line for support of high-throughput isolation of primary human B cells and monoclonal neutralizing antibodies.
Whaley R, Ameny S, Arkatkar T, Seese A, Wall A, Khan I
J Immunol Methods. 2020; 488:112901.
PMID: 33069767
PMC: 7560121.
DOI: 10.1016/j.jim.2020.112901.
Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
Yu F, Xiang R, Deng X, Wang L, Yu Z, Tian S
Signal Transduct Target Ther. 2020; 5(1):212.
PMID: 32963228
PMC: 7506210.
DOI: 10.1038/s41392-020-00318-0.
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives.
Parray H, Shukla S, Samal S, Shrivastava T, Ahmed S, Sharma C
Int Immunopharmacol. 2020; 85:106639.
PMID: 32473573
PMC: 7255167.
DOI: 10.1016/j.intimp.2020.106639.
Production and Characterization of Human Monoclonal Antibodies from the Cells of A(H1N1)pdm2009 Influenza Virus Infected Indian Donors.
Saxena L, Khanna M
Procedia Vaccinol. 2020; 9:50-58.
PMID: 32288920
PMC: 7128965.
DOI: 10.1016/j.provac.2015.05.009.
Development of Foot-and-Mouth Disease Virus-Neutralizing Monoclonal Antibodies Derived From Plasmablasts of Infected Cattle and Their Germline Gene Usage.
Li K, Wang S, Cao Y, Bao H, Li P, Sun P
Front Immunol. 2019; 10:2870.
PMID: 31867017
PMC: 6908506.
DOI: 10.3389/fimmu.2019.02870.
